Cerecor (CERC) – Management Comments
-
Cerecor (CERC) Reports First Patient Dosing in Phase 1b Proof-of-Concept Clinical Trial of CERC-007 for Treatment of Adult Onset Still’s Disease
-
Cerecor (CERC) Appoints Schond L. Greenway as Chief Financial Officer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CERC Stock Lookup